Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of menopausal hormone therapy on bone turnover markers in women after surgical menopause
TCTR20190808004Not yet recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Aug 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Trial of semaglutide + estradiol + progesterone in osteoporosis, sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoint: Change in bone turnover markers. Planned start Aug 2019; status: not yet recruiting.
02
Drugs
semaglutide + estradiol + progesterone
03
Conditions
osteoporosis
Beyond the preview
Go deeper on TCTR20190808004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190808004.